Yuishin Izumi

机构：Tokushima University · ORCID：0000-0001-8321-6963

发表论文 21 篇 · 总被引 694 次 · h-index 9

代表论文

• The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis (2017 · Science Translational Medicine · 被引 257)
• iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease (2017 · Cell Reports · 被引 233)
• Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem Cells (2021 · Annals of Neurology · 被引 52)
• Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs (2017 · Molecular Therapy — Nucleic Acids · 被引 43)
• Repurposing bromocriptine for Aβ metabolism in Alzheimer’s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer’s disease with presenilin 1 (PSEN1) mutations (2021 · BMJ Open · 被引 28)
• TDP-43 regulates cholesterol biosynthesis by inhibiting sterol regulatory element-binding protein 2 (2022 · Scientific Reports · 被引 25)